Dr Reddys Laboratories (RDY) Interest & Investment Income (2009 - 2026)
Dr Reddys Laboratories (RDY) recorded Interest & Investment Income of $31.57 million in the quarter ended Jun 30, 2026, up 12.6% from $28.04 million a year earlier and up 72.1% from the prior quarter.
Dr Reddys Laboratories (RDY) Interest & Investment Income (2009 - 2026) Analysis & Trends
On a TTM basis, Dr Reddys Laboratories' Interest & Investment Income came in at $92.91 million as of Jun 30, 2026, down 6.9% year-over-year; for the year ended Mar 31, 2026, it was $84 million, down 4.5% from the prior year.
- Annual Interest & Investment Income has a five-year compound annual growth rate of 18.5% (years ended Mar 2021 to Mar 2026).
- Across earlier years, Interest & Investment Income came in at $88 million in the year ended Mar 31, 2025 (+29.4%), $68 million in the year ended Mar 31, 2024 (+30.8%), $52 million in the year ended Mar 31, 2023 (+26.8%) and $41 million in the year ended Mar 31, 2022 (+13.9%).
- The figure for the quarter ended Jun 30, 2026 is the highest quarterly Interest & Investment Income since the quarter ended Mar 31, 2025.
- On a year-over-year basis, Interest & Investment Income rose in five of the last eight quarters, with growth averaging 28.8%.
- Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 894.7% in the quarter ended Sep 30, 2023, against a decline of 59.8% in the quarter ended Jun 30, 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $18.34 million (quarter ended Mar 31, 2026), $23.72 million (quarter ended Dec 31, 2025) and $19.27 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Dr Reddys Laboratories | 10.22 Bn | 9.41 Bn | 396.53 Mn | 31.57 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.57 Mn |
| Mar 31, 2026 | 18.34 Mn |
| Dec 31, 2025 | 23.72 Mn |
| Sep 30, 2025 | 19.27 Mn |
| Jun 30, 2025 | 28.04 Mn |
| Mar 31, 2025 | 34.74 Mn |
| Dec 31, 2024 | 9.45 Mn |
| Sep 30, 2024 | 27.60 Mn |
| Jun 30, 2024 | 17.20 Mn |
| Mar 31, 2024 | 19.45 Mn |
| Dec 31, 2023 | 16.30 Mn |
| Sep 30, 2023 | 19.09 Mn |
| Jun 30, 2023 | 14.06 Mn |
| Mar 31, 2023 | 14.03 Mn |
| Dec 31, 2022 | 3.40 Mn |
| Sep 30, 2022 | 1.92 Mn |
| Jun 30, 2022 | 34.96 Mn |
| Mar 31, 2022 | 15.63 Mn |
| Dec 31, 2021 | -11.00 Mn |
| Sep 30, 2021 | -4.00 Mn |
Dr Reddys Laboratories Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();